BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 12.90 Delayed Data As of 4:00pm ET |  +0.38 / +3.04%Today’s Change | 7.61 Today|||52-Week Range 19.99 | -6.86% Year-to-Date |
Latest BCRX News | Press Releases
No recent news for BioCryst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 12.52 |
| Today’s open | 12.71 |
| Day’s range | 12.54 - 13.03 |
| Volume | 158,384 |
| Average volume (3 months) | 2,840,110 |
| Market cap | $2.3B |
Data as of 4:00pm ET, 09/28/2022
Growth & Valuation
| Earnings growth (last year) | +5.98% |
| Earnings growth (this year) | -19.66% |
| Earnings growth (next 5 years) | +5.11% |
| Revenue growth (last year) | +782.38% |
| P/E ratio | NM |
| Price/Sales | 15.78 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARVNArvinas Inc | +2.23 | +5.16% |
| ---- | ||
| FATEFate Therapeutics In... | +1.26 | +5.76% |
| IBRXImmunitybio Inc | +0.52 | +10.46% |
Data as of 4:00pm ET, 09/28/2022
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $157.2M |
| Annual profit (last year) | -$184.1M |
| Net profit margin | -117.11% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
